ADCs a big opportunity for Big Pharma say experts

Big Pharma business opportunities driving ADC boom say experts

By Gareth Macdonald

Big Pharma interest in antibody drug conjugates (ADC) hit another high this week with Roche  ,Novartis and AstraZeneca each announcing investments that boost their ability to develop and manufacture these small-molecule monoclonal antibody (mAb) drug...